Biogen Executive and Leadership Team

Christopher Viehbacher, the President & Chief Executive Officer at Biogen, directs the company's overarching strategy and global operations. Viehbacher steers Biogen's mission to discover, develop, and deliver therapies for neurological and neurodegenerative diseases. This leadership involves guiding research and development initiatives, ensuring robust manufacturing processes, and overseeing the commercialization of critical treatments across the United States, Europe, Germany, Asia, and international markets. The President & Chief Executive Officer ensures alignment with the company's commitment to advancing scientific understanding and improving patient outcomes in areas such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. By fostering strategic partnerships and driving operational excellence, Christopher Viehbacher solidifies Biogen's position as a leader in neuroscience innovation and patient care.

Robert Kramer, the Executive Vice President & Chief Financial Officer at Biogen, oversees the company's financial strategy, planning, and operations. Kramer directs all aspects of financial management, including accounting, treasury, investor relations, and corporate development, ensuring fiscal responsibility and sustainable growth. This leadership role is critical for supporting Biogen's extensive research and development activities in neurological and neurodegenerative diseases. The Executive Vice President & Chief Financial Officer provides strategic financial guidance to drive investment in innovative therapies and optimize resource allocation across global operations. By maintaining financial discipline and pursuing strategic financial opportunities, Robert Kramer strengthens Biogen's capacity to deliver life-changing treatments and enhance shareholder value.

Carl Enell, the Chief Operating Officer at Biogen, manages the company's day-to-day operational functions and ensures efficient execution of its strategic objectives. Enell oversees critical aspects of Biogen's global operations, including manufacturing, supply chain management, and the delivery of therapies to patients worldwide. This role is pivotal in maintaining the high standards required for producing treatments for complex neurological and neurodegenerative diseases. The Chief Operating Officer drives process improvements and operational efficiencies across all facilities, ensuring product quality and timely market access. By optimizing resource allocation and streamlining workflows, Carl Enell supports Biogen's mission to bring innovative medicines to patients in need, reinforcing the company's commitment to operational excellence and global health impact.

Krystin Hein, the Chief of Staff Strategy, Medical Affairs Rare Disease & Neuropsychiatry Operations Lead (US) at Biogen, orchestrates strategic initiatives within key therapeutic areas. Hein focuses on aligning medical affairs strategies with operational execution for rare diseases and neuropsychiatry in the United States. This involves enhancing the development and deployment of treatments for conditions such as Alzheimer's disease and dementia, as well as Parkinson's disease and movement disorders. The Chief of Staff Strategy, Medical Affairs Rare Disease & Neuropsychiatry Operations Lead (US) ensures seamless integration between strategic planning and operational implementation, driving progress in clinical development and patient support programs. By fostering cross-functional collaboration, Krystin Hein advances Biogen's commitment to addressing unmet medical needs in complex neurological conditions.

Monirath Pao, the Chief Marketing Officer & Quality Engineer at Biogen, drives market strategy and ensures product quality across the organization. Pao leads the development and execution of comprehensive marketing plans for Biogen's portfolio of therapies, focusing on neurological and neurodegenerative diseases. This dual role emphasizes a commitment to both commercial success and stringent quality standards in pharmaceutical manufacturing. The Chief Marketing Officer & Quality Engineer oversees market analysis, brand management, and the effective communication of therapeutic benefits to healthcare professionals and patients. By integrating quality engineering principles into marketing operations, Monirath Pao ensures that Biogen's products meet the highest standards of safety and efficacy, supporting the company's mission to improve patient lives.

Guy Hadari, the Senior Vice President, Global Chief Information Officer at Biogen, directs the company's global information technology strategy and infrastructure. Hadari oversees the implementation of advanced technological solutions that support Biogen's research, development, manufacturing, and commercial operations. This leadership role is crucial for enabling data-driven decision-making and ensuring the security and integrity of the company's digital assets. The Senior Vice President, Global Chief Information Officer drives innovation in areas such as data analytics, cloud computing, and cybersecurity to enhance operational efficiency and accelerate therapeutic breakthroughs. By leveraging technology, Guy Hadari strengthens Biogen's capacity to address complex neurological diseases and deliver life-changing therapies to patients worldwide.

Amy Wilson, the Head of Strategic Operations, Pharmaceutical Operations & Technology Chief of Staff at Biogen, manages critical operational strategies within the company's pharmaceutical division. Wilson focuses on enhancing the efficiency and effectiveness of Biogen's pharmaceutical operations and technology functions. This involves overseeing strategic planning, process optimization, and the implementation of key initiatives across manufacturing and technology platforms. The Head of Strategic Operations, Pharmaceutical Operations & Technology Chief of Staff ensures that operational strategies are aligned with Biogen's broader goals of developing and delivering innovative therapies. By driving operational excellence, Amy Wilson supports the company's commitment to advancing treatments for neurological and neurodegenerative diseases and improving patient outcomes globally.

James Rouse, the Vice President, Chief Information Officer at Biogen, leads critical information technology initiatives supporting the company's operational and strategic objectives. Rouse oversees the deployment and management of technology infrastructure, ensuring robust systems for research, development, and commercial activities. This role is essential for maintaining the technological backbone that enables Biogen's work in neurological and neurodegenerative diseases. The Vice President, Chief Information Officer focuses on enhancing data security, optimizing IT resources, and implementing innovative solutions to support business growth. By driving technological advancements, James Rouse contributes to Biogen's mission of delivering life-changing therapies and improving patient care across its global operations.

Stephen Thompson, the Chief of Staff To The Head of Development at Biogen, provides strategic support and operational coordination for the company's development pipeline. Thompson works closely with the Head of Development to advance Biogen's portfolio of therapies for neurological and neurodegenerative diseases. This involves managing key projects, facilitating cross-functional communication, and ensuring alignment with development milestones. The Chief of Staff To The Head of Development plays a vital role in streamlining the drug development process, from early research to clinical trials and regulatory submissions. By enhancing operational efficiency within the development function, Stephen Thompson supports Biogen's commitment to bringing innovative treatments to patients and addressing critical unmet medical needs.

Cynthia Jones, the Chief of Staff, HI-Bio at Biogen, directs strategic operations and administrative functions for the HI-Bio division. Jones focuses on enhancing the operational effectiveness and strategic alignment of HI-Bio's initiatives within Biogen's broader framework. This role involves coordinating key projects, managing stakeholder communications, and ensuring the efficient execution of divisional objectives. The Chief of Staff, HI-Bio plays a crucial part in supporting the development and commercialization of therapies, particularly in areas of high unmet medical need. By driving operational excellence and strategic clarity, Cynthia Jones contributes to Biogen's mission of advancing scientific innovation and delivering impactful treatments to patients globally.